Brief: Medicenna to Provide Clinical Update on the MDNA11 ABILITY-1 Trial at the Upcoming American Association for Cancer Research Annual Meeting
26/03/2025 11:42
March 26 (Reuters) - Medicenna Therapeutics Corp MDNA.TO: MEDICENNA TO PROVIDE CLINICAL UPDATE ON THE MDNA11 ABILITY-1 TRIAL AT THE UPCOMING AMERICAN ASSOCIATION FOR CANCER RESEARCH ANNUAL MEETING Source text: ID:nGNX6Fmq4T Further company coverage: MDNA.TO ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medicenna Therapeutics
See all newsBrief: Medicenna Therapeutics - Announces Two New U.S. Patents And One Allowed U.S. Patent Application
Brief: Medicenna Announces The Finalization Of The Terms Of Its Public Offering Of Securities
Brief: Medicenna Announces The Launch Of A Marketed Public Offering Of Securities
Brief: Medicenna Therapeutics Appoints Dr. Nageatte Ibrahim As Chief Medical Officer
Brief: Medicenna Therapeutics Reports Third Quarter Fiscal 2026 Financial Results